NEW YORK (GenomeWeb News) — Cepheid said today VWR International will distribute its PCR-based detection technology in the US under a non-exclusive agreement.
 
Cepheid said the deal could expand its reach to more “government, academic and biotechnology laboratories” using PCR technology.
 
VWR will distribute Cepheid’s SmartCycler, which is used for genetic analysis and detection, and its SmartMix, which Cepheid said offers the reagents needed to perform PCR.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.